Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
| Study Number Sort descending | Lead Group | Study Title | CIRB | Study Status | |
|---|---|---|---|---|---|
| UAZ2015-05-02 | CP-CTNet_CLO-University of Arizona | M4OC-Prevent: Metformin for Oral Cancer Prevention | Cancer Prevention and Control CIRB | Completed | |
| UAZ2016-08-02 | CP-CTNet_CLO-University of Arizona | A feasibility trial of alternating intravaginal application of 5-fluorouracil and imiquimod for treatment of high-grade cervical squamous intraepithelial lesions | Cancer Prevention and Control CIRB | Available to Open | |
| UAZ2017-09-02 | CP-CTNet_CLO-University of Arizona | Clinical Study of Avmacol® for Detoxification of Tobacco Carcinogens in Heavy Smokers | Cancer Prevention and Control CIRB | Completed | |
| UAZ21-06-01 | CP-CTNet_CLO-University of Arizona | Phase II Randomized, Double Blind, Placebo-Controlled Trial of the Broccoli Seed and Sprout Extract (BSSE), Avmacol ES, to Evaluate Sustained Detoxification of Tobacco Carcinogens in Heavy Smokers | Cancer Prevention and Control CIRB | Available to Open | |
| UAZ21-07-01 | CP-CTNet_CLO-University of Arizona | M4OC-Prevent 2.0: Phase IIb Trial of Metformin for Oral Cancer Prevention | Cancer Prevention and Control CIRB | Available to Open | |
| UMI21-05-01 | CP-CTNet_LAO-University of Michigan | Obeticholic Acid for Prevention in Barrett’s Esophagus | Cancer Prevention and Control CIRB | Available to Open | |
| UMI22-09-01 | CP-CTNet_LAO-University of Michigan | Phase IIA Trial of Acolbifene (20 mg) vs Low Dose Tamoxifen (5 mg) in Pre-menopausal Women at High Risk for Development of Breast Cancer | Cancer Prevention and Control CIRB | Available to Open | |
| UMI23-13-01 | CP-CTNet_LAO-University of Michigan | An Early Phase 1 Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy | Cancer Prevention and Control CIRB | Available to Open | |
| URCC-16070 | NCORP-University of Rochester Cancer Center | Treatment of Refractory Nausea | Cancer Prevention and Control CIRB | Available to Open | |
| URCC-16092 | NCORP-University of Rochester Cancer Center | Phase II Study of Low-Dose Ibuprofen for Cognitive Problems in Patients with Cancer | Cancer Prevention and Control CIRB | Available to Open |